Use of therapeutic drug monitoring in the long-term valaciclovir therapy of relapsing herpes simplex virus encephalitis in children

被引：7

作者：

Lim, Ming ^{[1
]}

Menson, Esse ^{[2
]}

Tong, C. Y. William ^{[3
]}

Lin, Jean-Pierre ^{[1
]}

机构：

[1] Guys & St Thomas Hosp NHS Fdn Trust, Evelina Childrens Hosp, Paediat Neurol Dept, London, England

[2] Guys & St Thomas Hosp NHS Fdn Trust, Evelina Childrens Hosp, Dept Paediat, London, England

[3] Guys & St Thomas Hosp NHS Fdn Trust, Directorate Infect, London, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2009年 / 64卷 / 06期

关键词：

aciclovir; paediatric; brain; central nervous system penetration; ACYCLOVIR; VALACYCLOVIR;

D O I：

10.1093/jac/dkp373

中图分类号：

R51 [传染病];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1340 / 1341

页数：2

共 9 条

[1]

Valacyclovir: A review of its antiviral activity, pharmacokinetic properties, and clinical efficacy [J].

Beutner, KR .

ANTIVIRAL RESEARCH, 1995, 28 (04) :281-290

[2]

BLUM MR, 1982, AM J MED, V73, P186

[3]

Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy:: Can intravenous acyclovir be substituted by oral valacyclovir? [J].

Eksborg, S ;

Pal, N ;

Kalin, M ;

Palm, C ;

Söderhäll, S .

MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 38 (04) :240-246

[4]

Enright Andrea M, 2003, Herpes, V10, P32

[5]

Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir [J].

Ito, Y ;

Kimura, H ;

Yabuta, Y ;

Ando, Y ;

Murakami, T ;

Shiomi, M ;

Morishima, T .

CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) :185-187

[6]

Simple high performance liquid chromatography (HPLC) assay for aciclovir and ganciclovir in serum [J].

McMullin, CM ;

Kirk, B ;

Sunderland, J ;

White, LO ;

Reeves, DS ;

MacGowan, AP .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (04) :739-740

[7]

HERPES-SIMPLEX ENCEPHALITIS WITH RELAPSE [J].

PIKE, MG ;

KENNEDY, CR ;

NEVILLE, BGR ;

LEVIN, M .

ARCHIVES OF DISEASE IN CHILDHOOD, 1991, 66 (10) :1242-1244

[8]

DOSING CONSIDERATIONS FOR ORAL ACYCLOVIR FOLLOWING NEONATAL HERPES DISEASE [J].

RUDD, C ;

RIVADENEIRA, ED ;

GUTMAN, LT .

ACTA PAEDIATRICA, 1994, 83 (12) :1237-1243

[9]

Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness [J].

Simon M.W. ;

Fish D.N. ;

Deeter R.G. .

Drugs in R & D, 2002, 3 (6) :365-373

← 1 →